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Review title and timescale
Review title
Give the working title of the review. This must be in English. Ideally it should state succinctly the interventions or exposures being reviewed and the associated health or social problem being addressed in the review. Systematic review and meta-analysis of the effect of alcohol consumption on specific types of cancer and severe lung diseases 2
Original language title
For reviews in languages other than English, this field should be used to enter the title in the language of the review. This will be displayed together with the English language title. 
Review team details
6
Named contact
The named contact acts as the guarantor for the accuracy of the information presented in the register record. Evangelia Simou 
Review methods
Review question(s)
State the question(s) to be addressed / review objectives. Please complete a separate box for each question. How does alcohol consumption impact on specific cancers and severe lung diseases on adults?
Searches
Give details of the sources to be searched, and any restrictions (e.g. language or publication period). The full search strategy is not required, but may be supplied as a link or attachment.
We will search the following electronic bibliographic databases: MEDLINE (via Ovid), EMBASE (via Ovid) and Web of Science. Studies published between 1985 and the date the searches are run will be sought. Emphasis will be given on the most recent studies. A 'search diary' will be kept giving details for the search strategy, including the names of the databases searched, the search terms used and the search results The search filter used by SIGN will be adopted to retrieve systematic reviews. Search terms for each health outcome will be developed from search strategies from relevant Cochrane Review groups. There will be no language restrictions.
URL to search strategy
If you have one, give the link to your search strategy here. Alternatively you can e-mail this to PROSPERO and we will store and link to it.
I give permission for this file to be made publicly available Yes
Condition or domain being studied
Give a short description of the disease, condition or healthcare domain being studied. This could include health and wellbeing outcomes. A full list of the outcomes being assessed are given under 'Primary outcomes' below.
Participants/population
Give summary criteria for the participants or populations being studied by the review. The preferred format includes details of both inclusion and exclusion criteria. Inclusion: Adults aged 18 and over. Exclusion: Adults 18 years and older who do not consume alcohol.
Intervention(s), exposure(s)
Give full and clear descriptions of the nature of the interventions or the exposures to be reviewed All studies which have assessed the effect of alcohol consumption defined as ever alcohol drinkers, ex-or former drinkers will be included. For the alcohol to include all drinking levels: light, moderate and heavy drinking, according to drinks/day or gr of ethanol/day), as defined in the included studies. Alternatively, for the drinking levels will be defined: 1 unit as 8 g or 10ml of ethanol, and light as ‹ 2 units per day; moderate as 2-3 units per day; heavy as >= 4 units per day, in accordance with standard recommended alcohol allowance guidance (UK). If a study does not report the alcohol consumption levels, a dichotomy of any alcohol consumption versus non-alcohol consumption will be used. We will exclude studies on special populations (alcoholics, patients HBV/HCV infected) and studies referred only on specific types of alcoholic beverages.
Comparator(s)/control
Where relevant, give details of the alternatives against which the main subject/topic of the review will be compared (e.g. another intervention or a non-exposed control group).
The comparison group will be adults who are not exposed to alcohol, or where drinking levels are considered within the included studies. Also, the comparison groups will be adults who are exposed to lower levels of alcohol consumption.
Types of study to be included
Give details of the study designs to be included in the review. If there are no restrictions on the types of study design eligible for inclusion, this should be stated. We will include longitudinal or cohort studies which have assessed the effect of alcohol on the outcomes of interest. Where there is limited longitudinal evidence for particular outcomes, we will also include case control studies.
Context
Give summary details of the setting and other relevant characteristics which help define the inclusion or exclusion criteria.
Primary outcome(s)
Give the most important outcomes. We will include all studies which assess the effect of alcohol on the incidence of the disease. Diagnosis of incidence of disease from death certificates will also be eligible for inclusion. We will also assess the effect of alcohol on specific cancer: Upper aerodigestive tract cancers (oral cavity, larynx,pharynx, esophagus), colorectum, liver, female breast, prostate, lung, bladder, pancreatic, endometrial, ovarian, skin cancer, renal cell, small intestine and leukemia. We will examine the association between alcohol and severe lung diseases: pneumonia, tuberculosis, acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma and sleep apnoea. Give information on timing and effect measures, as appropriate. We will include all relative effect measures, for example Hazard Ratios, Odds Ratios, risk Ratios.
Secondary outcomes
List any additional outcomes that will be addressed. If there are no secondary outcomes enter None. None Give information on timing and effect measures, as appropriate.
Give the procedure for selecting studies for the review and extracting data, including the number of researchers involved and how discrepancies will be resolved. List the data to be extracted. Two reviewers will examine independently both the titles and the abstracts that have identified by electronic search in order to select the relevant included articles. Then the full text of potentially eligible articles will be searched and read by the reviewers, checking each paper against the inclusion criteria. Any disagreements will be resolved through discussion with a third reviewer. Two reviewers will independently screen all the studies and abstracted the following information in a piloted and standard format: study design, time period, participants, exposures, study setting and outcomes related to cancer and severe lung diseases. Disagreements regarding eligibility will be resolved through discussion or with a third reviewer.
Risk of bias (quality) assessment
State whether and how risk of bias will be assessed, how the quality of individual studies will be assessed, and whether and how this will influence the planned synthesis. Two reviewers will independently conduct the quality assessment and the risk of bias of the included studies using the Newcastle-Ottawa Scale for longitudinal and cohort studies and the Assessment of Multiple systematic Reviews (AMSTAR) Scale for systematic reviews. Disagreements between the review authors over the risk of bias in particular studies will be resolved by discussion, with involvement of a third review author where necessary.
Strategy for data synthesis
Give the planned general approach to be used, for example whether the data to be used will be aggregate or at the level of individual participants, and whether a quantitative or narrative (descriptive) synthesis is planned. Where appropriate a brief outline of analytic approach should be given. We will conduct a meta-analysis to synthesize the data. We will extract specific effect measures for the association between alcohol consumption and the risk of the disease (cancer or lung infection). Risk estimates will be reported as odds ratios (OR), risk ratios (RR), hazard ratios (HR) or incidence rate ratios (IRR) with 95% confidence intervals (CI). We will use a random effect meta-analytic model to calculate summary estimates of similar studies. The I2 statistics will be used to evaluate heterogeneity and forest plots used for the graphic investigation of the heterogeneity. Also, funnel plots will be used to visually assess evidence of publication bias. We will also conduct sensitivity analysis by excluding each study at a time from the meta-analysis to assess the influence of individual studies on the pooled effect measure. All the statistical analyses will be carried out using the STATA software and Review Manager 5.3 version software.
Analysis of subgroups or subsets
Give any planned exploration of subgroups or subsets within the review. 'None planned' is a valid response if no subgroup analyses are planned. If the necessary data are available,we will perform subgroup and meta-regression analyses to assess reasons for heterogeneity between the studies, based on the geographical area (studies conducted in Europe compared to the rest of the world), sex, and whether the results were adjusted for confounding.
Review general information
Type and method of review
Select the type of review and the review method from the drop down list. Epidemiologic, Systematic review
Language
Select the language(s) in which the review is being written and will be made available, from the drop down list. Use the control key to select more than one language. English Will a summary/abstract be made available in English? Yes
Country
Select the country in which the review is being carried out from the drop down list. For multi-national collaborations select all the countries involved. Use the control key to select more than one country. England
Other registration details
Give the name of any organisation where the systematic review title or protocol is registered together with any unique identification number assigned. If extracted data will be stored and made available through a repository such as the Systematic Review Data Repository (SRDR), details and a link should be included here.
Reference and/or URL for published protocol
Give the citation for the published protocol, if there is one. Give the link to the published protocol, if there is one. This may be to an external site or to a protocol deposited with CRD in pdf format.
I give permission for this file to be made publicly available
Yes
Dissemination plans
Give brief details of plans for communicating essential messages from the review to the appropriate audiences.
A qualitative evaluation will be conducted to gain an understanding of the public's beliefs of the harms of alcohol on health. All the findings from these reviews will be used to develop a comprehensive website, where the target audiences are the academic community, professionals and general public. This website will also be evaluated by the users to ensure it is understandable and accessible to the aforementioned targeted groups Do you intend to publish the review on completion? Yes
Keywords
Give words or phrases that best describe the review. (One word per box, create a new box for each term) systematic review meta-analysis alcohol cancer lung diseases 37 Details of any existing review of the same topic by the same authors
Give details of earlier versions of the systematic review if an update of an existing review is being registered, including full bibliographic reference if possible.
Current review status
Review status should be updated when the review is completed and when it is published. Ongoing
Any additional information
Provide any further information the review team consider relevant to the registration of the review.
Details of final report/publication(s)
This field should be left empty until details of the completed review are available. Give the full citation for the final report or publication of the systematic review.
Give the URL where available.
